Cigna Corp vs Sibanye Stillwater Ltd — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Sibanye Stillwater Ltd trades at $10.54 (market cap $7.61B). The key difference: Cigna Corp is far larger — about 9.7× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| CI | SBSW | |
|---|---|---|
Market Cap | $73.56B | $7.61B |
Sector | Health | Basic Materials |
52-Week High | $311.00 | $21.12 |
52-Week Low | $244.41 | $7.27 |
Enterprise Value | $98.27B | $9.26B |
Dividend Yield | 2.24% | 2.91% |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Sibanye Stillwater (SBSW) surged 7.6% to $10.64, showing strong momentum despite negative profitability metrics. The stock trades at attractive valuation multiples with P/E of 4.76 and P/S of 0.95, while technical indicators signal bullish momentum. Recent earnings misses contrast with analyst optimism, with 42.9% recommending Buy and a $14.25 consensus target. The company faces challenges with negative net income margins but shows improving cash flow projections for 2025.
SBSW presents a value opportunity with deep undervaluation metrics, though profitability concerns and recent earnings misses warrant caution. The bullish technical setup and analyst support suggest potential upside, but investors must weigh the company's debt reduction progress against persistent negative margins. Key catalysts include PGM price recovery and management's debt reduction targets.
Trailing returns across standard periods
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →